Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1992; Volume 261,Issue 2
  • You have access
    (+-)-1-hydroxy-3-aminopyrrolidone-2 (HA-966) inhibits the activity of substantia nigra dopamine neurons through a non-N-methyl-D-aspartate receptor-mediated mechanism.
    P D Shepard and H Lehmann
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 387-394;
  • You have access
    Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels.
    A M Allan, L D Baier and X Zhang
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 395-402;
  • You have access
    Direct in vitro electrochemical measurement of dopamine overflow in intermediate pituitary: characterization and pharmacology.
    P J Williams, T V Dunwiddie and G A Gerhardt
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 403-411;
  • You have access
    Benzimidazolone derivatives: a new class of 5-hydroxytryptamine4 receptor agonists with prokinetic and acetylcholine releasing properties in the guinea pig ileum.
    C A Rizzi, T Coccini, L Onori, L Manzo and M Tonini
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 412-419;
  • You have access
    In utero cocaine exposure: effect on neonatal breathing in guinea pigs.
    G D Olsen and J A Weil
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 420-428;
  • You have access
    The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
    S G Taylor, J R Arch, J Bond, D R Buckle, D J Shaw, J F Taylor and J S Ward
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 429-437;
  • You have access
    Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes.
    L C Schlichter, P A Pahapill and I Chung
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 438-446;
  • You have access
    Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    M Johnson, I Elayan, G R Hanson, R L Foltz, J W Gibb and H K Lim
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 447-453;
  • You have access
    Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    W R Millington, G P Mueller and G J Lavigne
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 454-461;
  • You have access
    Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
    L B Kinter, I McConnell, B T Goodwin, S Campbell, W F Huffman, M F Arthus, M Lonergan and D G Bichet
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 462-469;
  • You have access
    Effect of clentiazem on arterial pressure and renal function in normotensive and hypertensive rats.
    F J Fenoy, I Milicic, M Mistry, T E Mecca and R J Roman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 470-475;
  • You have access
    Sensitization of locus ceruleus neurons during withdrawal from chronic stimulants and antidepressants.
    G C Harris and J T Williams
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 476-483;
  • You have access
    Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections.
    P Vezina, G Blanc, J Glowinski and J P Tassin
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 484-490;
  • You have access
    Human cytochrome P450 metabolism of teniposide and etoposide.
    M V Relling, R Evans, C Dass, D M Desiderio and J Nemec
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 491-496;
  • You have access
    Myosin phosphorylation-independent contraction induced by phorbol ester in vascular smooth muscle.
    K Sato, M Hori, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi and H Karaki
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 497-505;
  • You have access
    Receptor agonists induce myosin phosphorylation-dependent and phosphorylation-independent contractions in vascular smooth muscle.
    M Hori, K Sato, K Sakata, H Ozaki, H Takano-Ohmuro, T Tsuchiya, H Sugi, I Kato and H Karaki
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 506-512;
  • You have access
    Increased rates of punished responding produced by buspirone-like compounds in rats.
    D J Sanger
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 513-517;
  • You have access
    Transport of salicylic acid through monolayers of a kidney epithelial cell line (LLC-PK1).
    J Y Chatton and F Roch-Ramel
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 518-524;
  • You have access
    Acute sensitivity of FAST and SLOW mice to the effects of abused drugs on locomotor activity.
    T J Phillips, S Burkhart-Kasch, C C Gwiazdon and J C Crabbe
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 525-533;
  • You have access
    Relaxant effects of beta-carbolines on rat aortic rings.
    B Elgoyhen, P S Lorenzo, M T Tellez-Iñón and E Adler-Graschinsky
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 534-539;
  • You have access
    Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide.
    I Findlay
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 540-545;
  • You have access
    Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    C V Jackson, V G Crowe, J D Frank, H C Wilson, W J Coffman, B G Utterback, J A Jakubowski and G F Smith
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 546-552;
  • You have access
    Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
    V B Schini and P M Vanhoutte
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 553-559;
  • You have access
    Prolactin regulates maternal bile secretory function post partum.
    Y Liu, J F Hyde and M Vore
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 560-566;
  • You have access
    Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
    C B Tyler and M P Galloway
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 567-573;
  • You have access
    Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    D J Wiedemann, P A Garris, J A Near and R M Wightman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 574-579;
  • You have access
    K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors.
    A J Murgo and F D Sistare
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 580-585;
  • You have access
    Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    M Johnson, K Mitros, D M Stone, R Zobrist, G R Hanson and J W Gibb
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 586-591;
  • You have access
    Use of 2-hydroxypropyl-beta-cyclodextrin as an intrathecal drug vehicle with opioids.
    J Jang, T L Yaksh and H F Hill
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 592-600;
  • You have access
    Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
    R A Foy, J L Myles and R D Wilkerson
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 601-606;
  • You have access
    Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.
    R D Spealman and J Bergman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 607-615;
  • You have access
    Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    G A Ricaurte, A L Martello, J L Katz and M B Martello
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 616-622;
  • You have access
    The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
    R W Foltin and M W Fischman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 623-632;
  • You have access
    Perinatal changes in the coupling of beta 1- and beta 3 adrenergic receptors to brown fat adenylyl cyclase.
    A Chaudhry, K N Lahners and J G Granneman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 633-637;
  • You have access
    Effects of agonist exposure on the coupling of beta 1 and beta 3 adrenergic receptors to adenylyl cyclase in isolated adipocytes.
    J G Granneman
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 638-642;
  • You have access
    Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice.
    K S Arts, J M Fujimoto and L F Tseng
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 643-651;
  • You have access
    Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
    Q S Yan, P K Mishra, R L Burger, A F Bettendorf, P C Jobe and J W Dailey
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 652-659;
  • You have access
    Adenosine receptor-mediated alterations in prostacyclin production and cardiac function in the isolated rabbit heart.
    C Cano and K U Malik
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 660-668;
  • You have access
    Role of different brain structures in the expression of the physical morphine withdrawal syndrome.
    R Maldonado, L Stinus, L H Gold and G F Koob
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 669-677;
  • You have access
    Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation.
    J Q Wang and A J Ingenito
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 678-685;
  • You have access
    Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619.
    M Y Farhat and P W Ramwell
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 686-691;
  • You have access
    Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats.
    T B Tzeng and H L Fung
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 692-700;
  • You have access
    Effect of lithium and amiloride on collecting tubule transport enzymes.
    E Dafnis, N A Kurtzman and S Sabatini
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 701-706;
  • You have access
    Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem.
    S R Hamann and W R Martin
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 707-715;
  • You have access
    Hepatic cytochrome P-450-mediated activation of rat aortic guanylyl cyclase by glyceryl trinitrate.
    B M Bennett, B J McDonald and M J St James
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 716-723;
  • You have access
    Blocking action of terodiline on calcium channels in single smooth muscle cells of the guinea pig urinary bladder.
    H Kura, M Yoshino and H Yabu
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 724-729;
  • You have access
    Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    T Nakajima, T Shinohara, O Yaoka, A Fukunari, K Shinagawa, K Aoki, A Katoh, T Yamanaka, M Setoguchi and T Tahara
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 730-736;
  • You have access
    AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    W W Reenstra, L M Pinkus, J Bailey, W L Smith, D Droppleman, L F Sancilio and J G Forte
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 737-745;
  • You have access
    Alpha adrenoceptor subtypes involved in the emetic action in dogs.
    Y Hikasa, S Ogasawara and K Takase
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 746-754;
  • You have access
    Phasic responses to carbachol in isolated guinea pig trachea are augmented by cooling and inhibited by nifedipine.
    T M Tagliente, B A Dalton and R R Ben-Harari
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 755-763;
  • You have access
    Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats.
    Y Takano and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 764-772;
  • You have access
    Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
    J Van Wauwe, G Van Nyen, M C Coene, P Stoppie, W Cools, J Goossens, P Borghgraef and P A Janssen
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 773-779;
  • You have access
    Effect of inflammation on the rabbit hepatic cytochrome P-450 isoenzymes: alterations in the kinetics and dynamics of tolbutamide.
    C Parent, P M Bélanger, L Jutras and P du Souich
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 780-787;
  • You have access
    The alcohol-preferring C57BL/6 mice present an enhanced sensitivity of the hypothalamic beta-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice.
    J P De Waele, D N Papachristou and C Gianoulakis
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 788-794;
  • You have access
    Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit.
    F Holmquist, H J Kirkeby, B Larsson, A Forman, P Alm and K E Andersson
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 795-802;
  • You have access
    Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma.
    D J Brat, A J Windebank and S Brimijoin
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 803-810;
  • You have access
    Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity.
    J D Steketee and P W Kalivas
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 811-818;
  • You have access
    Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
    L H Lash and R K Zalups
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 819-829;
  • You have access
    Endothelial dopamine DA-1 receptor sites in the rabbit pulmonary artery: autoradiographic demonstration.
    A Ricci, W L Collier and F Amenta
    Journal of Pharmacology and Experimental Therapeutics May 1992, 261 (2) 830-834;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 261, Issue 2
1 May 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics